ENGLISH - Hepatitis C Awareness in Armenia

ENGLISH Vertical Version

MSB228206

If you think this image is in any way inappropriate, please report it, by including its URN/identifying code and a brief description of your concern in sending an email to [email protected]

Linked assets

INTER - Hepatitis C Awareness in Armenia

No Subtitles (international)

Hepatitis C Awareness in Armenia

Add to lightbox

Add to cart

Unique Identifier Code / URN MSB228206

Date taken / Date Recorded 10/04/2025 12:00 AM

Expiration date 10/04/2030

Country Armenia

Commissioning section MSF-SWITZERLAND

Photographer / videographer / producer Myrto Mouzaki

Copyright Myrto Mouzaki/MSF

Usage Rights (MSF) Advertising Campaign, External Media, MSF Publications, Social Media

Formal Consent Copy available no

Editor's rating ★★★ (F)

Video format h264 (High) (avc1 / 0x31637661)

Duration 1m25s

Maximum Size 1080px × 1920px 71.14 MB

Additional Information / Shotlist Hepatitis C remains a significant public health challenge in Armenia, affecting many people, particularly key populations such as MSM, PWIDs, and prisoners. While the disease is curable, access to testing and treatment has often been limited due to financial, logistical, and awareness-related barriers. In response, Médecins Sans Frontières (MSF) partnered with Arshakunyats Health Center in 2023 to launch a dedicated Hepatitis C project aimed at making care more accessible.

A key component of this project is the Key Population Unit, which follows a "one-stop-shop" model, allowing patients to receive testing, diagnosis, consultations, and treatment in a single location, free of charge. This initiative began in April 2024, and since then, it has helped many patients navigate their journey to recovery more easily and effectively.

Since April 2024, the Key Population Unit within the polyclinic has been providing free essential healthcare to all, without discrimination or stigma. Its goal is to encourage more people to seek care and contribute to Armenia’s national goal to eliminate Hepatitis C.